Lv1
10 积分 2022-11-07 加入
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation
2天前
已完结
DihydrofolateReductase (DHFR) Inhibitors: A Comprehensive Review
11个月前
已完结
Recent advances in the development of STING inhibitors: an updated patent review
1年前
已完结
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
1年前
已完结
Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001–2021)
1年前
已完结
Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR
1年前
已完结
719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors
1年前
已完结
CCNE1 Amplification and PKMYT1 Inhibition Are Synthetic Lethal
2年前
已关闭
CCNE1 Amplification and PKMYT1 Inhibition Are Synthetic Lethal
2年前
已关闭
皖公网安备34019202002308
